Related Experiment Videos
[Improvement of flow properties using Arwin in acute experimental infarct]
Zeitschrift Fur Kardiologie
|November 1, 1976
Summary
Arwin treatment reduced blood viscosity by lowering fibrinogen levels during experimental myocardial infarction. However, it did not significantly reduce electrocardiographic evidence of myocardial injury or reperfusion arrhythmias in dogs.
Area of Science:
- Cardiovascular Research
- Pharmacology
- Experimental Medicine
Context:
- Acute myocardial infarction involves reduced blood flow and increased blood viscosity.
- Arwin, a fibrinogen-lowering agent, was investigated for its potential to mitigate ischemic injury.
- Experimental models are crucial for understanding therapeutic interventions in cardiovascular events.
Purpose:
- To evaluate the effect of Arwin on blood viscosity and myocardial injury in an acute experimental infarction model.
- To assess the impact of Arwin-induced fibrinogen reduction on electrocardiographic markers of infarction.
- To determine if Arwin influences hemodynamic parameters or reperfusion arrhythmias.
Summary:
- Arwin infusion significantly decreased plasma fibrinogen concentration and blood viscosity in dogs with experimentally induced coronary artery occlusion.
- Electrocardiographic evidence of myocardial injury (ST-segment elevation) and infarct size were not significantly reduced by Arwin treatment.
- Hemodynamic parameters remained similar between Arwin-treated and control groups, and a significant difference in reperfusion arrhythmias was not established.
Impact:
- This study suggests that reducing blood viscosity via fibrinogen lowering with Arwin may not be sufficient to reduce myocardial injury in acute experimental infarction.
- The findings indicate that Arwin's potential benefits for conditions like angina pectoris cannot be predicted from this model.
- Further research is needed to explore alternative mechanisms or therapeutic strategies for managing acute myocardial infarction.